Paradromics, a brain-computer interface startup, has made a significant advancement by successfully implanting its device Connexus in a human patient, who was having brain surgery for epilepsy. This milestone, occurring alongside a growing interest in brain-computer technologies, reflects a concerted effort to help those with spinal cord injuries, strokes, or ALS communicate effectively. The device, capable of translating neural signals into synthesized speech and digital interaction, was previously tested in sheep, and its first human trial signals a new phase of development for the company and its innovative approach to neurotechnology.
"There's a very unique opportunity when someone is undergoing a major neurosurgical procedure... the marginal risk of testing out a brain implant is actually very low."
"With the Connexus, Austin-based Paradromics is looking to restore speech and communication in people with spinal cord injury, stroke, or amyotrophic lateral sclerosis."
Collection
[
|
...
]